• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾移植受者他克莫司免疫抑制治疗后的胰岛素抵抗指数。

Insulin resistance indexes in renal transplant recipients maintained on tacrolimus immunosuppression.

机构信息

University Hospital Birmingham, Edgbaston, Birmingham, United Kingdom.

出版信息

Transplantation. 2010 Feb 15;89(3):327-33. doi: 10.1097/TP.0b013e3181bbf2c4.

DOI:10.1097/TP.0b013e3181bbf2c4
PMID:20145524
Abstract

BACKGROUND

Insulin resistance is common posttransplantation and contributes to both new onset diabetes after transplantation and the metabolic syndrome. Insulin resistance indexes have never been validated in transplant recipients on tacrolimus compared with cyclosporine, although it is more diabetogenic. We aimed to assess these indexes in renal transplant recipients on tacrolimus as primary immunosuppressant.

METHODS

Retrospective analysis of 76 frequently sampled, intravenous glucose tolerance tests (for insulin sensitivity) in 38 nondiabetic renal transplant recipients on tacrolimus-centered immunosuppression. Indexes tested were fasting glucose/insulin ratio, homeostasis model assessment (HOMA) index, 1/HOMA, log (HOMA), quantitative insulin sensitivity check index, and the McAuley's index. Indexes were also compared against waist/hip ratio and C-reactive protein (CRP). Multivariate linear regression analysis was performed to determine independent variables predictive for insulin resistance.

RESULTS

Insulin sensitivity successfully correlated with all indexes: fasting glucose/insulin ratio (r=0.246, P=0.033), HOMA index (r=-0.240, P=0.038), 1/HOMA (r=0.282, P=0.014), log (HOMA) (r=-0.316, P=0.006), quantitative insulin sensitivity check index (r=0.320, P=0.005), and McAuley's index (r=0.323, P=0.005). McAuley's index also correlated strongest with waist/hip ratio (r=-0.425, P<0.001). All indexes failed to correlate with CRP. Variables independently associated with insulin sensitivity were HbA1c (r=0.189, P=0.019), pulse pressure (r=0.146, P=0.021), and CRP (r=0.210, P=0.010).

CONCLUSIONS

Insulin resistance indexes are valid in transplant recipients taking tacrolimus, with McAuley's index the strongest surrogate.

摘要

背景

胰岛素抵抗在移植后很常见,它既导致移植后新发糖尿病,也导致代谢综合征。虽然他克莫司比环孢素更具致糖尿病性,但尚未在接受他克莫司治疗的移植受者中对胰岛素抵抗指数进行验证,而这些指数是在环孢素治疗的移植受者中进行验证的。我们旨在评估这些在接受他克莫司为主要免疫抑制剂的肾移植受者中的指标。

方法

对 38 例接受他克莫司为中心免疫抑制治疗的非糖尿病肾移植受者的 76 次频繁采样静脉葡萄糖耐量试验(用于评估胰岛素敏感性)进行回顾性分析。检测的指标包括空腹血糖/胰岛素比值、稳态模型评估(HOMA)指数、1/HOMA、log(HOMA)、定量胰岛素敏感性检查指数和 McAuley 指数。还将这些指标与腰围/臀围比和 C 反应蛋白(CRP)进行了比较。进行多元线性回归分析,以确定预测胰岛素抵抗的独立变量。

结果

胰岛素敏感性与所有指标均成功相关:空腹血糖/胰岛素比值(r=0.246,P=0.033)、HOMA 指数(r=-0.240,P=0.038)、1/HOMA(r=0.282,P=0.014)、log(HOMA)(r=-0.316,P=0.006)、定量胰岛素敏感性检查指数(r=0.320,P=0.005)和 McAuley 指数(r=0.323,P=0.005)。McAuley 指数与腰围/臀围比相关性最强(r=-0.425,P<0.001)。所有指标均与 CRP 无相关性。与胰岛素敏感性独立相关的变量是 HbA1c(r=0.189,P=0.019)、脉压(r=0.146,P=0.021)和 CRP(r=0.210,P=0.010)。

结论

在接受他克莫司治疗的移植受者中,胰岛素抵抗指数是有效的,其中 McAuley 指数的相关性最强。

相似文献

1
Insulin resistance indexes in renal transplant recipients maintained on tacrolimus immunosuppression.肾移植受者他克莫司免疫抑制治疗后的胰岛素抵抗指数。
Transplantation. 2010 Feb 15;89(3):327-33. doi: 10.1097/TP.0b013e3181bbf2c4.
2
Validation of insulin resistance indexes in a stable renal transplant population.稳定肾移植人群中胰岛素抵抗指数的验证
Diabetes Care. 2005 Oct;28(10):2424-9. doi: 10.2337/diacare.28.10.2424.
3
Impending hyperglycemia in normoglycemic renal transplant recipients--an experimental predictive surrogate.肾功能正常的移植受者即将发生的高血糖症——一种实验性预测替代指标。
Transplantation. 2010 Jun 15;89(11):1341-6. doi: 10.1097/TP.0b013e3181d9e1d8.
4
Insulin hyposecretion in nondiabetic, tacrolimus-treated renal transplant recipients more than 6 months posttransplantation.肾移植术后6个月以上接受他克莫司治疗的非糖尿病患者胰岛素分泌不足。
Transplantation. 2009 Jun 27;87(12):1870-6. doi: 10.1097/TP.0b013e3181a767b3.
5
Conversion from Tacrolimus to Cyclosporine A Improves Glucose Tolerance in HCV-Positive Renal Transplant Recipients.从他克莫司转换为环孢素A可改善丙型肝炎病毒阳性肾移植受者的糖耐量。
PLoS One. 2016 Jan 6;11(1):e0145319. doi: 10.1371/journal.pone.0145319. eCollection 2016.
6
Role of insulin resistance indices in predicting new-onset diabetes after kidney transplantation.胰岛素抵抗指数在预测肾移植后新发糖尿病中的作用。
Transpl Int. 2013 Mar;26(3):273-80. doi: 10.1111/tri.12026. Epub 2012 Dec 11.
7
Glucose metabolism in the first 3 years after renal transplantation in patients receiving tacrolimus versus cyclosporine-based immunosuppression.接受他克莫司与环孢素为基础的免疫抑制治疗的肾移植患者术后3年内的葡萄糖代谢情况。
J Am Soc Nephrol. 2002 Jan;13(1):213-220. doi: 10.1681/ASN.V131213.
8
The role of proinflammatory cytokine gene polymorphisms for development of insulin resistance after renal transplantation.促炎细胞因子基因多态性在肾移植后胰岛素抵抗发生中的作用。
Transplant Proc. 2006 Mar;38(2):521-8. doi: 10.1016/j.transproceed.2006.01.041.
9
Beta Cell Function and Insulin Resistance After Conversion from Tacrolimus Twice-Daily to Extended-Release Tacrolimus Once-Daily in Stable Renal Transplant Recipients.稳定肾移植受者从每日两次他克莫司转换为每日一次缓释他克莫司后的β细胞功能和胰岛素抵抗
Ann Transplant. 2016 Dec 16;21:765-774. doi: 10.12659/aot.900638.
10
Diabetes mellitus after transplant: relationship to pretransplant glucose metabolism and tacrolimus or cyclosporine A-based therapy.移植后糖尿病:与移植前糖代谢及基于他克莫司或环孢素A的治疗的关系。
Transplantation. 2003 Nov 15;76(9):1320-6. doi: 10.1097/01.TP.0000084295.67371.11.

引用本文的文献

1
Nodular glomerulosclerosis in a kidney transplant recipient with impaired glucose tolerance: diabetic or idiopathic? A case report and literature review.糖耐量受损的肾移植受者的结节性肾小球硬化症:糖尿病还是特发性?病例报告及文献复习。
CEN Case Rep. 2021 May;10(2):273-280. doi: 10.1007/s13730-020-00546-x. Epub 2021 Jan 3.
2
Impaired mitochondrial calcium uptake caused by tacrolimus underlies beta-cell failure.他克莫司导致的线粒体钙摄取受损是β细胞衰竭的基础。
Cell Commun Signal. 2017 Nov 13;15(1):47. doi: 10.1186/s12964-017-0203-0.
3
Liver Enzymes and the Development of Posttransplantation Diabetes Mellitus in Renal Transplant Recipients.
肾移植受者的肝酶与移植后糖尿病的发生
Transplant Direct. 2017 Aug 28;3(9):e208. doi: 10.1097/TXD.0000000000000717. eCollection 2017 Sep.
4
Prediabetes in Pediatric Recipients of Liver Transplant: Mechanism and Risk Factors.肝移植儿科受者的糖尿病前期:机制与危险因素
J Pediatr. 2017 Mar;182:223-231.e3. doi: 10.1016/j.jpeds.2016.11.070. Epub 2016 Dec 29.
5
Comparing glycaemic benefits of Active Versus passive lifestyle Intervention in kidney Allograft Recipients (CAVIAR): study protocol for a randomised controlled trial.肾移植受者主动与被动生活方式干预血糖获益比较研究(CAVIAR):一项随机对照试验的研究方案
Trials. 2016 Aug 22;17(1):417. doi: 10.1186/s13063-016-1543-6.
6
Characterization of Remitting and Relapsing Hyperglycemia in Post-Renal-Transplant Recipients.肾移植受者缓解期和复发期高血糖的特征分析
PLoS One. 2015 Nov 9;10(11):e0142363. doi: 10.1371/journal.pone.0142363. eCollection 2015.
7
Pancreatic β-cell dysfunction and risk of new-onset diabetes after kidney transplantation.胰腺β细胞功能障碍与肾移植后新发糖尿病的风险。
Diabetes Care. 2013 Jul;36(7):1926-32. doi: 10.2337/dc12-1894. Epub 2013 Feb 1.
8
Early basal insulin therapy decreases new-onset diabetes after renal transplantation.早期基础胰岛素治疗可降低肾移植后新发糖尿病的风险。
J Am Soc Nephrol. 2012 Apr;23(4):739-49. doi: 10.1681/ASN.2011080835. Epub 2012 Feb 16.